All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

70-Year-Old Runner Hospitalized After Insurer Delays Lifesaving Immunodeficiency Drug

By

Samantha Liss, KFF Health News

1d ago· 7 min readenNews

Summary

Margaret Hvatum, a 70-year-old part-time computer science professor with a weakened immune system, ran an extraordinary series of races (5K, 10K, half-marathon, and full marathon over four consecutive days) in January, only to end up hospitalized later that month. Despite insurers publicly vowing to help patients access lifesaving immunodeficiency drugs, Hvatum struggled to obtain her critical weekly medication for primary immunodeficiency, missing several doses. The article examines the gap between insurance company promises and the real-world challenges patients face in accessing prescribed treatments.

Source

bsky70-Year-Old Runner Hospitalized After Insurer Delays Lifesaving Immunodeficiency Drugmedpagetoday.com

Key quotes

· 4 pulled
Over 4 consecutive days in January, Margaret Hvatum ran a 5K, a 10K, a half-marathon, and a full marathon.
The 70-year-old covered a combined distance that's nearly equivalent to running the length of Manhattan four times.
By the end of the month, she was in a hospital bed.
Hvatum, a part-time computer science professor, has a weakened immune system
Snippet from the RSS feed
Medicare Advantage patient missed several weekly doses for her primary immunodeficiency

You might also wanna read

Unplugged: How a Heart Attack at 52 Woke Me Up to the Biggest Lie in Medicine - Mark Kaplan's Memoir on Genetic Heart Disease

A memoir by former top-ranked tennis pro Mark Kaplan, who suffered a heart attack at 52 despite appearing to be in peak physical condition.

a.co·16d ago

Patient reflects on decades of progress in sickle cell treatment

Audrey Patricia Smith, 78, reflects on her lifelong experience with sickle cell disease, from her first pain crisis at age 12 in 1959 to the

hub.jhu.edu·8d ago

Health researcher survives 14-minute cardiac arrest thanks to daughter's coaches' CPR and AED

Dr. Kevin Volpp, a health policy researcher and physician, suffered a cardiac arrest at a Cincinnati restaurant while traveling for his daug

heart.org·10d ago

Health researcher survives 14-minute cardiac arrest thanks to daughter's coaches' CPR and AED

Dr. Kevin Volpp, a health policy researcher and physician, suffered a cardiac arrest at a Cincinnati restaurant while traveling for his daug

heart.org·10d ago

Health researcher survives 14-minute cardiac arrest thanks to daughter's coaches' CPR and AED

Dr. Kevin Volpp, a health policy researcher and physician, suffered a cardiac arrest at a Cincinnati restaurant while traveling for his daug

heart.org·10d ago

Health researcher survives 14-minute cardiac arrest thanks to daughter's coaches' CPR and AED

Dr. Kevin Volpp, a health policy researcher and physician, suffered a cardiac arrest at a Cincinnati restaurant while traveling for his daug

heart.org·10d ago

75-Year-Old Retiree with Alzheimer's Trains for Marathons, Refusing to Let Diagnosis Slow Him Down

Ralph C. Carmona, now 75, was diagnosed with mild cognitive impairment due to Alzheimer's disease in 2015 after his wife noticed memory issu

People.com·1mo ago

European Multiple Myeloma Patients Face Unequal Access to Curative Treatments

At the European Hematology Association (EHA) 2026 Congress in Stockholm, speakers highlighted that while new drugs and treatment combination

mdsc.pe·7d ago

Mayo Clinic physicians propose 'healthspan' framework to reframe aging beyond lifespan

Mayo Clinic physicians Christina Chen, M.D., and Sara Bonnes, M.D., propose a new framework for "healthspan" — the years of life spent in go

mayocl.in·5d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.